There will be multiple 10 point up days imo. Too many irons in the fire to make this a one trick pony. Investors will extrapolate any efficacy in ALS to stroke and spinal cord injury cases...where a much broader application will result in greater health care cost savings and improvement in quality of life for the patients. Throw in NS-189 efficacy with its broad application and the numbers are staggering.
I sold some the day before XMAS for gifts and travel but never wired the money out of the trading acct. So today I put an order in at $2.60 but didn't get filled and then quickly moved it up to 2.66. I had a feeling if I did not move the price up, I could be left way behind. I was right, and very fortunate.
I still think the stock should be about $5 or $6 dollars now and with various news events this coming year should rise to $15 or $20. I say "should". But We've all seen it happen before and it could happen to us. ALS approval alone is worth $15 or more IMHO.
And yes Buddha, "extrapolate" is the multiplier word - as in to the moon!
Or as Jackie Gleason would say " To the moon Shorty" :)